Survival Prospects For Melanoma Patients Indicated By Interleukin-12
Apr 17th 2008Drug InformationCancer
Higher blood levels of an immune system protein predict poor survival prospects for melanoma patients with advanced disease, researchers at The University of Texas M. D. Anderson Cancer Center report at the annual meeting of the American Association for Cancer Research.Their finding that elevated levels of interleukin-12 (IL-12) are a marker of poor prognosis also points to a molecular explanation for a long-known risk factor for melanoma patients - older age.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
